Bridgeway Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-100,000
| Closed | -$102K | – | 1242 |
|
|
2024
Q4 | $102K | Hold |
100,000
| – | – | ﹤0.01% | 1109 |
|
|
2024
Q3 | $86.6K | Buy |
+100,000
| New | +$86.6K | ﹤0.01% | 1171 |
|
|
2024
Q2 | – | Sell |
-222,300
| Closed | -$149K | – | 1336 |
|
|
2024
Q1 | $149K | Sell |
222,300
-72,700
| -25% | -$48.7K | ﹤0.01% | 1155 |
|
|
2023
Q4 | $160K | Hold |
295,000
| – | – | ﹤0.01% | 1178 |
|
|
2023
Q3 | $177K | Buy |
+295,000
| New | +$177K | ﹤0.01% | 1128 |
|